
Asia Morning Oct 26
Market sentiment is supported by reports that drug-makers Johnson & Johnson and AstraZeneca will resume trials of COVID-19 vaccines...
Share this:
Dow Jones Industrial Average (Daily Chart) : Bias Remains Bullish
Sources: GAIN Capital, TradingView
Market sentiment was supported by reports that drug-makers Johnson & Johnson (JNJ +0.11%) and AstraZeneca will resume trials of COVID-19 vaccines. Meanwhile, Gilead Sciences' (GILD +0.20%) drug remdesivir became the first COVID-19 treatment approved by the Food and Drug Administration.
Media (+1.3%), Retailing (+0.96%) and Consumer Durables & Apparel (+0.96%) sectors performed the best, while Semiconductors & Semiconductor Equipment (-1.09%), Automobiles & Components (-0.86%) and Energy (-0.55%) sectors lagged behind.
Nordstrom (JWN +5.60%) was the top gainer. On the other hand, Intel Corp (INTC -10.58%) plunged after its quarterly results missed expectations.
European stocks were broadly higher. The Stoxx Europe 600 Index rose 0.62%, Germany's DAX 30 climbed 0.82%, France's CAC 40 jumped 1.20% and the U.K.'s FTSE 100 was up 1.29%.
U.S. Treasury prices ticked up, as the benchmark 10-year Treasury yield edged down to 0.840% from 0.845% Thursday.
Spot gold dipped $1 (-0.08%) to $1,902 an ounce.
U.S. WTI crude futures (December) fell $0.88 (-2.17%) to $39.76 a barrel.
On the forex front, the U.S. dollar resumed its weakness against other major currencies. The ICE Dollar Index dropped 0.20% to 92.76. On a daily chart, the 20-day moving average has crossed below the 50-day one. The Markit U.S. Manufacturing Purchasing Managers Index (PMI) (preliminary reading) edged up to 53.3 in October (53.5 expected).
EUR/USD rebounded 0.37% to 1.1862. On technical terms, the pair has confirmed a bullish signal of 20-day/ 50-day moving-average-crossover. The Markit Eurozone Manufacturing PMI (preliminary reading) rose to 54.4 in October (53.0 expected).
GBP/USD was down for a second day as it slipped 0.33% to 1.3039. U.K. official data showed that retail sales gained 1.5% on month in September (+0.2% expected), while the GfK consumer confidence index fell to -31 in October (-28 expected). The Markit U.K. Manufacturing PMI (preliminary reading) posted at 53.3 for October (53.1 expected).
USD/JPY slipped 0.12% to 104.73. Official data showed that Japan's Consumer Prices were flat on year in September (as expected).
AUD/USD gained 0.32% to 0.7140, while USD/CAD dipped a further 0.09% to 1.3124.
Dow Jones Industrial Average (Daily Chart) : Bias Remains Bullish
Sources: GAIN Capital, TradingView
Market sentiment was supported by reports that drug-makers Johnson & Johnson (JNJ +0.11%) and AstraZeneca will resume trials of COVID-19 vaccines. Meanwhile, Gilead Sciences' (GILD +0.20%) drug remdesivir became the first COVID-19 treatment approved by the Food and Drug Administration.
Media (+1.3%), Retailing (+0.96%) and Consumer Durables & Apparel (+0.96%) sectors performed the best, while Semiconductors & Semiconductor Equipment (-1.09%), Automobiles & Components (-0.86%) and Energy (-0.55%) sectors lagged behind.
Nordstrom (JWN +5.60%) was the top gainer. On the other hand, Intel Corp (INTC -10.58%) plunged after its quarterly results missed expectations.
European stocks were broadly higher. The Stoxx Europe 600 Index rose 0.62%, Germany's DAX 30 climbed 0.82%, France's CAC 40 jumped 1.20% and the U.K.'s FTSE 100 was up 1.29%.
U.S. Treasury prices ticked up, as the benchmark 10-year Treasury yield edged down to 0.840% from 0.845% Thursday.
Spot gold dipped $1 (-0.08%) to $1,902 an ounce.
U.S. WTI crude futures (December) fell $0.88 (-2.17%) to $39.76 a barrel.
On the forex front, the U.S. dollar resumed its weakness against other major currencies. The ICE Dollar Index dropped 0.20% to 92.76. On a daily chart, the 20-day moving average has crossed below the 50-day one. The Markit U.S. Manufacturing Purchasing Managers Index (PMI) (preliminary reading) edged up to 53.3 in October (53.5 expected).
EUR/USD rebounded 0.37% to 1.1862. On technical terms, the pair has confirmed a bullish signal of 20-day/ 50-day moving-average-crossover. The Markit Eurozone Manufacturing PMI (preliminary reading) rose to 54.4 in October (53.0 expected).
GBP/USD was down for a second day as it slipped 0.33% to 1.3039. U.K. official data showed that retail sales gained 1.5% on month in September (+0.2% expected), while the GfK consumer confidence index fell to -31 in October (-28 expected). The Markit U.K. Manufacturing PMI (preliminary reading) posted at 53.3 for October (53.1 expected).
USD/JPY slipped 0.12% to 104.73. Official data showed that Japan's Consumer Prices were flat on year in September (as expected).
AUD/USD gained 0.32% to 0.7140, while USD/CAD dipped a further 0.09% to 1.3124.
Related tags:
Latest market news
View more newsOpen an account in minutes
Experience award-winning platforms with fast and secure execution, and enjoy tight spreads from 0.5 pts on FX and 0.3 pts on indices.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

S&P 500 forecast: Stocks extend drop as correction risks grow
US and global equity markets have extended Wednesday’s sell-off, with Wall Street opening lower after a weak handover from Asia and Europe. The deterioration in risk appetite has been spreading across global markets. The dollar was firmer, Treasury yields were holding onto yesterday’s gains, while gold, silver and bitcoin were all under pressure alongside equities and major currencies.

WTI Crude Oil Mulls Bounce from $90
Having fallen 17% from its cycle highs in just five days and now holding above $90, perhaps it could be time for crude oil to bounce over the near term.

ASX 200 Rebound Stalls Despite Wall Street Surge
The ASX 200 rebound is struggling for traction despite a powerful Wall Street rally, leaving 8800 resistance and downside risks in focus.
This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.
StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.
In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.
StoneX Financial Pte. Ltd. is not under any obligation to update this report.
Trading CFDs carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit www.forex.com/en-sg/terms-and-policies for the complete Risk Disclosure Statement.






